what are they actually doing there?
A compass pointing West
Researchers at PSI have discovered a new phenomenon of magnetism with the help of the Swiss Light Source SLS. Certain groups of atoms behave like a compass pointing West. This could make computers much more powerful.
Cladding tubes and their properties
In the Nuclear Energy and Safety Research Division at PSI, Johannes Bertsch focuses on the so-called cladding tubes that are used in nuclear power plants.
Children are her passion
At PSI, Beate Timmermann built up a programme providing proton therapy for children with cancer at the same time she was raising her own son. Today she is head of the Clinic for Particle Therapy at the West German Proton Therapy Centre in Essen (WPE) and is considered one of the most accomplished experts in this field.
Watching electrons and switching bits on
Electronics should get smaller, faster, and above all more energy-efficient. These themes are also present in several research groups at PSI. From incremental improvements to complete rethinking – who is currently working on what?
Virtual lens improves X-ray microscopy
A method developed by PSI researchers makes X-ray images of materials even better. The researchers took a number of individual images while moving an optical lens. From these, with the help of computer algorithms, they generated one overall image.
Now it's time for something new
If you make electronic components smaller, they unfortunately get hotter. Also, we will soon reach the limit of technically feasible miniaturisation. At PSI, Gabriel Aeppli and Christian Rüegg are working on fundamentally new, physical solutions for better computers and data storage devices.
Measurement of five flashes from the depths of the universe
A PSI-developed detector called POLAR has collected data on so-called gamma-ray bursts from a space station. This is now helping to better understand these extremely high-energy flashes of light.
New paths for energy with hydrogen
At the ESI Platform at the Paul Scherrer Institute PSI, researchers are seeking solutions for Switzerland's energy future and improving the efficiency of modern forms of renewable energy. With a mini gas turbine, they now have closed another energy cycle.
EU grants 14 million to Swiss Researchers
A team with three researchers from the ETH Domain has been awarded a prestigious EU grant. Today, they received the contract signed by the EU confirming the extraordinary 14 million euros funding. With it, they will investigate quantum effects which could become the backbone of future electronics.
On the go at 200 kilometres per hour
Fabia Gozzo is no woman for the comfort zone. First she made a beamline at the Swiss Light Source SLS of the Paul Scherrer Institute PSI into one of the world's leading facilities. Today she is making her knowledge available to industry with her spin-off.
Making the impossible possible
Use of multiferroic materials promises more energy-efficient computers because in these, an electric field would suffice to achieve magnetic data storage. Researchers at PSI have now made such a material suitable for computer operating temperatures.
Why the Little Ice Age ended in the middle of the 19th century
In the first half of the 19th century, a series of large volcanic eruptions in the tropics led to a temporary global cooling of Earth's climate. That Alpine glaciers grew and subsequently receded again during the final phase of the so-called Little Ice Age was due to a natural process. This has now been proven by PSI researchers on the basis of ice cores.
30 years Paul Scherrer Institute PSI
Ceremony with invited guests from politics, business and sciencePSI held its 30 Years of PSI ceremony. The PSI showed guests what it has achieved over the past three decades, with results that could be of benefit to everyone in Switzerland.
Licence agreement with Swiss pharma firm for development of a cancer drug
A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.
This time, it's all bio: SwissFEL makes protein structures visible
For the development of new medicinal agents, accurate knowledge of proteins is crucial. In a pilot experiment, researchers have now, for the first time, used the X-ray free-electron laser SwissFEL of PSI for the examination of protein crystals.